Clinical Trials for The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Find clinical trials for the efficacy of abiraterone acetate combined with dalpicilib in the treatment of patients with metastatic castration-resistant prostate cancer. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06500247

This clinical trial is studying a new treatment approach for men with advanced metastatic castration-resistant prostate cancer, a type of prostate cancer that no longer responds to hormone therapy....

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions